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generation of CD44+CD24- cells through 
SDF-1/CXCR4 interaction
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Abstract
Background: Breast cancer stem cells (BCSCs) have been recently identified in breast carcinoma as CD44+CD24- cells, 
which exclusively retain tumorigenic activity and display stem cell-like properties. Using a mammosphere culture 
technique, MCF7 mammosphere cells are found to enrich breast cancer stem-like cells expressing CD44+CD24-. The 
stromal cells are mainly constituted by fibroblasts within a breast carcinoma, yet little is known of the contributions of 
the stromal cells to BCSCs.
Methods: Carcinoma-associated fibroblasts (CAFs) and normal fibroblasts (NFs) were isolated and identified by 
immunohistochemistry. MCF7 mammosphere cells were co-cultured with different stromal fibroblasts by a transwell 
cocultured system. Flow cytometry was used to measure CD44 and CD24 expression status on MCF7. ELISA (enzyme-
linked immunosorbent assay) was performed to investigate the production of stromal cell-derived factor 1 (SDF-1) in 
mammosphere cultures subject to various treatments. Mammosphere cells were injected with CAFs and NFs to 
examine the efficiency of tumorigenity in NOD/SCID mice.
Results: CAFs derived from breast cancer patients were found to be positive for α-smooth muscle actin (α-SMA), 
exhibiting the traits of myofibroblasts. In addition, CAFs played a central role in promoting the proliferation of 
CD44+CD24- cells through their ability to secrete SDF-1, which may be mediated to SDF-1/CXCR4 signaling. Moreover, 
the tumorigenicity of mammosphere cells with CAFs significantly increased as compared to that of mammosphere 
cells alone or with NFs.
Conclusion: We for the first time investigated the effects of stromal fibroblasts on CD44+CD24- cells and our findings 
indicated that breast CAFs contribute to CD44+CD24- cell proliferation through the secretion of SDF-1, and which may 
be important target for therapeutic approaches.
Introduction
B r e a s t  c a n c e r  i s  t h e  m o s t  f r e q u e n t  m a l i g n a n cy  a m o n g
women, about 1.05 million women suffer from and
373,000 die from breast cancer per year worldwide [1].
Most recent studies indicate that breast cancer is mainly
caused by breast cancer stem cells (BCSCs), and the cure
for breast cancer requires BCSCs be eradicated [2,3]. In
2003, Clarke and colleagues demonstrated that a highly
tumorigenic subpopulation of BCSCs, expressing
CD44+CD24- surface marker in clinical specimen, had the
capacity to form tumors with as few as one hundred cells,
whereas tens of thousands of the bulk breast cancer cells
did not [3]. The concept of a cancer stem cell within a
tumor mass, as an aberrant form of normal differentia-
tion, is now gaining acceptance [4-6]. In order to simplify
research procedure, some cancer cell lines were used to
study BCSCs instead of patient samples, because they
were found to have cancer stem-like cell potential. For
instance, mammosphere cells were found to enrich breast
cancer stem-like cells with the phenotype of
CD44+CD24- [7].
Until now, studies on breast cancer onset and develop-
ment have been mainly focused on the epithelial compo-
nents of the tumor, paying little attention to the
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surrounding tumor stromal niche. However, new evi-
dences have emerged suggesting an important interaction
between mammary epithelia and the adjacent tumor
stroma. For example, only normal fibroblasts (NFs) but
not carcinoma-associated fibroblasts (CAFs) exhibit the
ability to inhibit the proliferation of the tumorigenic
MCF10AT, suggesting that the ability of normal stromal
fibroblasts to control the dysregulation of epithelial cell
proliferation during breast carcinogenesis [8]. In addi-
tion, the gene expression profile of stromal fibroblasts
varies widely during cancer progression, among which it
includes many genes encoding secreted proteins, such as
chemokines [9,10].
Chemokines are a superfamily of small molecule
chemoattractive cytokines that mediate several cellular
functions. SDF-1 is a member of the CXC subfamily of
chemokines, and interacts with the seven-transmem-
brane G-protein-coupled receptor CXCR4. It is expressed
by stromal cells, including fibroblasts and endothelial
cells [11,12]. Normal primary mammary epithelial cells
derived from different donors do not express CXCR4
mRNA [11]. In contrast, functional CXCR4 is widely
expressed by different types of cancer cells. In addition,
CXCR4 is found to be expressed in numerous types of
embryonic and adult stem cells, which can be chemoat-
tracted by its ligand SDF-1. Thus, it is likely that SDF-1/
CXCR4 signaling plays an important role in stem cell
function during the early development [13,14].
Recently, it has been reported that dysregulation in the
mammary gland niche lead to abnormal expression of
transforming growth factor α (TGFα), resulting in the
development of breast cancer [15]. Moreover, vascular
niches in brain tumors were detected to be abnormal and
contributed directly to the generation of cancer stem cells
and tumor growth [16]. Based on these experimental
data, we hypothesized that dysregulation of the stromal
niche lead to uncontrolled proliferation of stem cells,
which may be the reason for tumorigenesis. In this study,
we demonstrated that CAFs enhanced the expression of
BCSC markers in secondary mammosphere cells and
promoted the tumorigenicity of mammosphere cells in
NOD/SCID mice. In addition, we proposed that SDF-1/
CXCR4 signaling is involved in the cell proliferation of
these cultured mammosphere cells.
Materials and methods
Mammosphere culture and dissociation
In our previous studies, we have showed that MCF7 cell
line had the highest mammosphere-forming efficiency
(MFE) among many breast cancer cells, so MCF7 cells
were chosen to generate mammosphere cells in vitro [17].
Cells were then washed twice with PBS and cultured in
suspension at a density of 2 × 105/bottle in DMEM/F12
(HyClone, Logan, Utah) with high glucose, supplemented
with 1 × B27 (Invitrogen), 20 ng/ml insulin-like growth
factor I (Invitrogen), 20 ng/ml EGF (Sigma, St. Louis,
MO) and 20 ng/ml b-FGF (Invitrogen). In all experi-
ments, cells were maintained at 37°C in a humidified 5%
CO2/95% air atmosphere. When MCF7 cells were grown
in suspension for six days, "primary mammospheres"
were obtained, then collected by gravity or gentle centrif-
ugation (800 g, 10 sec), and trypsinized with 0.05%
trypsin/0.53 mM EDTA-4Na (Invitrogen, Carlsbard, CA).
These cells were sieved through a 40-μm nylon mesh,
analyzed microscopically for single cellularity and
counted. The "secondary mammospheres" were gener-
ated in culture of 2 × 105 primary mammosphere cells/
bottle in the same media.
Flow cytometry
CD24 and CD44 expression was analyzed in cells derived
from monolayer cultures or in 6-day-cultured primary
mammospheres following incubation in trypsin-EDTA or
dissociation with a pipette and passage through a 40-μm
sieve. At least 1 × 105 cells were pelleted by centrifugation
at 500 g for 5 min at 4°C, resuspended in 10 μL of fluores-
cein isothiocyanate (FITC)-conjugated mouse anti-
human CD24 monoclonal antibody and allophycocyanin
(APC)-conjugated mouse anti-human CD44 monoclonal
antibody (BD Pharmingen, San Diego), and incubated at
4°C in the dark for 30 to 40 min. The labeled cells were
washed and then analyzed on a FACS (fluorescence acti-
vated cell sorting) Vantage (BD Biosciences).
Quantitative real time-polymerase chain reaction (qRT-
PCR)
After mammosphere cells were sorted, total RNA was
extracted by using RNeasy Mini kit (Qiagen, Valencia,
CA) and used for qRT-PCR assays in an ABI PRISM
7900HT sequence detection system (ABI, Norwalk, Con-
necticut). The specific PCR primers were used to detect
the presence of Notch2 (F: TATTGATGACTGCCCTAA
CCACA; R: ATAGCCTCCATTGCGGTTGG), β-catenin
(F: CCTTTGTCCCGCAA ATCATG; R: ACGTACG-
GCGCTGGGTATC),  CXCR4  (F: TACACCGAG-
GAAATG GGCTCA; R: TTCTTCACGGAAACAGGG
TTC),  SDF-1  (F: ATGCCCATGCCGA TTCTTCG; R:
GCCGGGCTACAATCTGAAGG) and GAPDH (F: ATG-
GGGAAGG TGAAGGTCG; R: GGGGTCATTGATG-
GCAACAATA). All reactions were done in a 10-μl
reaction volume in triplicate. PCR amplification con-
sisted of 10 min of an initial denaturation step at 95°C,
followed by 55 cycles of PCR at 95°C for 30 sec, 56°C for
30 sec and 72°C for 15 sec. Standard curves were gener-
ated and the relative amount of target gene mRNA was
normalized to GAPDH. Specificity was verified by melt
curve analysis and agarose gel electrophoresis.Huang et al. Journal of Experimental & Clinical Cancer Research 2010, 29:80
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Antagonist reagents
Mammosphere cells and monolayer cells of 2 × 105 were
cultured in medium (2 ml), and AMD3100, an antagonist
of CXCR4, was added to the medium at 1 μg/ml. Then
the cells were incubated at 37°C and 5% CO2 for 48 hours.
qRT-PCR was used to detect CXCR4 expression in mam-
mosphere cells and monolayer cells. Each experiment was
conducted in triplicate.
Tissue collection and cell preparation
Breast cancer specimens were collected from primary
tumors of 4 patients who underwent surgery at Xinhua
hospital. Signed informed consent was obtained from all
the patients. For comparison, we have also obtained nor-
mal tissue from healthy women after plastic surgery. The
tissues were minced and dissociated in DMEM/F12 sup-
plemented with 2% bovine serum albumin, 5 mg/ml insu-
lin, 300 U/ml collagenase and 100 U/ml hyaluronidase
(all from Sigma) at 37°C for 18 h. The epithelial-cell-rich
pellet was collected by centrifuging at 80 g for 4 min, fol-
lowed by one wash with DMEM/F12. The supernatant
from the first centrifugation was used as a source of
mammary stromal fibroblasts. Briefly, the first superna-
tant were concentrated by centrifugation at 100 g for 10
min, and the obtained mammary stromal fibroblasts were
resuspended and cultured in flasks in DMEM/F12 sup-
plemented with 5% fetal bovine serum (Sijiqing, Hang-
zhou, China) and 5 mg/ml insulin. Differential
trypsinization was applied during subculturing to select
for the growth of fibroblasts.
Immunohistochemistry
Coverslips with attached cells were fixed with formalde-
hyde for 5 min, and then stained with anti-human α-SMA
(Dako, Denmark) antibody according to the manufac-
turer's instruction. Cells showing light brown or yellow
brown grains in the cytoplasm were classified as posi-
tively staining.
Coculture of breast stromal fibroblasts with primary 
mammosphere cells
Coculture of primary mammosphere cells (1 × 105 cells/
dish) with breast stromal fibroblasts (1 × 105 cells/dish)
were performed by using a transwell (BD) cell culture sys-
tem, which allows free diffusion of substances without
contact between cancer cells and stromal fibroblasts.
Stromal fibroblasts in the insert layer were subcultured
on a transwell cell culture membrane (7.5 cm in diameter;
pore size: 0.4 μm), and mammosphere cells in the bottom
layer were maintained in a 10-cm Petri dish. Stromal
fibroblasts were precultured in DMEM/F12 with 10%
FBS for 48 h before the start of coculture. Stromal fibro-
blasts were maintained in fresh serum-free DMEM/F12
medium, and mammosphere cells were cultured in sus-
pension for six days.
Coinoculation of mammosphere cells with different 
stromal fibroblasts in vivo
Mammospheres and fibroblasts were collected, enzymat-
ically dissociated, washed in PBS, and kept at 4°C. Mice
were maintained in laminar flow rooms under constant
temperature and humidity and received an estradiol sup-
plementation (0.6 mg/kg, s.i., Sigma) every 7 days for 28
days before cell injection. The mammosphere cells (1 ×
105) admixed with either CAFs (1 × 105) or NFs (1 × 105)
were suspended in 0.1 ml of DMEM/F12 and then inocu-
lated into the mammary fat pad of 5-week-old female
NOD/SCID mice (Shanghai Experimental Animal Cen-
ter, Chinese Academy of Sciences, Shanghai, China).
Mice were examined by palpation for tumor formation
for up to 12 weeks, and then were sacrificed by cervical
dislocation. The histologic features of the xenografts were
examined by hematoxylin and eosin staining. All experi-
mentation performed with NOD/SCID mice, as well as
routine care of the animals, was carried out in accordance
with the institutional guide of animal care & use commit-
tee.
Measurement of SDF-1
The baseline level of SDF-1 production was determined
by coculture of mammosphere cells with stromal fibro-
blasts for six days at a density of 1 × 105/bottle. The con-
centration of SDF-1 in the supernatant was measured by
using a human SDF-1 antibody and enzyme immunoas-
say kit (R&D Systems, Minneapolis, MN), according to
the manufacturer's instructions.
Statistical analysis
Statistical analysis was performed by using GraphPad
Prism 4.0 software© (San Diego, CA). Student's t-test (for
comparison between two groups) or ANOVA with Tukey
post test (for comparison between more than two groups)
were used to determine whether there exists statistically
significance. Fisher exact probability test was used to ana-
l y z e  t u m o r i g e n i c i t y  i n  N O D / S C I D  m i c e .  D a t a  i s  p r e -
sented as the mean ± SEM. P  values of ≤ 0.05 were
regarded as being statistically significant.
Results
Primary mammosphere cells expressed higher BCSC 
markers and genes associated with stem cells
In order to validate the generation of cancer stem-like
cells through mammosphere culture, flow cytometry was
used to assess the expression of BCSC marker on primary
mammosphere cells and monolayer culture cells. As illus-
trated in Fig. 1A, when mammospheres were cultured in
suspension for six days, the proportion of CD44+CD24-Huang et al. Journal of Experimental & Clinical Cancer Research 2010, 29:80
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cells were significantly increased as compared with that
of MCF7 monolayer cells (7.9 ± 0.8% vs. 1.9 ± 0.1%, P <
0.01), which suggest that mammosphere cells can be used
to enrich BCSCs. In addition, qRT-PCR analysis indi-
cated that stem cell associated genes, such as Notch2 and
β-catenin, were expressed in mammosphere cells at
higher levels than that in monolayer cells (Fig. 1B).
CAFs expressed high levels of α-SMA
Primary stromal fibroblasts were cultured in DMEM/F12
supplemented with 5% fetal bovine serum and 5 mg/ml
insulin, and no epithelial cells were detected in passage 3
stromal fibroblasts. Although the morphology and
growth pattern of CAFs and NFs was similar (Fig. 2A),
immunohistochemical staining showed that CAFs exhib-
Figure 1 Mammosphere cells contained subpopulations of cells expressing prospective BCSC markers. (A) FACS analysis to measure CD44 
and CD24 expression of cells derived from MCF7 monolayer cultures (left) or primary mammospheres (right), which were cultured in suspension for 
six days. The expression of CD44+CD24- in mammosphere cells was (7.9 ± 0.8%), compared with (1.9 ± 0.1%) for the monolayer culture cells, P < 0.01. 
A minimum of 10,000 events were collected per sample. (B) qRT-PCR showed that Notch2 and β-catenin mRNA expression in mammosphere cells 
were at higher levels by around 4.0 and 3.1 fold than that in monolayer cells, respectively, P <0.01. The data were provided as the mean ± SD. Each 
experiment was performed three times.Huang et al. Journal of Experimental & Clinical Cancer Research 2010, 29:80
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ited strongly positive expression of α-SMA, whereas NFs
did not (Fig. 2B). In addition, this increased expression of
α-SMA in CAFs was maintained for up to eight passages
in vitro, indicating that isolated CAFs contained a high
proportion of myofibroblasts.
CAFs promoted the generation of CD44+CD24- cells in 
mammosphere cells
To determine whether CAFs affect the generation of can-
cer stem-like cells in mammosphere cells, we cocultured
primary mammosphere cells with stromal fibroblasts in
transwells for six days. It was observed that cocultured
mammosphere cells with CAFs siginicantly increased
MFE (13.5 ± 1.2% vs. 8.1 ± 0.7, P < 0.01), and mammo-
sphere cell number (3.82 ± 0.41 × 105 vs. 1.51 ± 0.43, P <
0.01) as compared to that of mammosphere cells culture
alone. In contrast, NFs markedly inhibit MFE (5.2 ± 0.6 %
vs. 8.1 ± 0.7, P < 0.05), and cell number (0.65 ± 0.22 × 105
vs. 1.51 ± 0.43, P < 0.01) as compared to that of mammo-
sphere cells culture alone (Table 1 and Fig. 3A). In addi-
tion, we used flow cytometry to assess the proportion of
BCSCs that has the phenotypic marker of CD44+CD24-,
and found that CAFs significantly increased the propor-
tion of CD44+CD24- cells in mammospheres (21.4 ± 1.8%
vs. 17.2 ± 2.3%, P < 0.05); while NFs decreased the pro-
portion of CD44+CD24- cells in mammospheres (8.7 ±
0.9% vs. 17.2 ± 2.3%, P < 0.01) (Fig. 3B, and see Additional
file 1), which exhibited similar trend as MFE. These
results suggest that CAFs have positive effects on the gen-
eration of CD44+CD24- cells, while NFs have negative
effects on CD44+CD24- cell formation.
CAFs had a positive role on the tumorigenicity of 
mammosphere cells
To investigate whether altered stromal niche could influ-
ence the tumorigenicity in vivo, we evaluated the tumor
formation in NOD/SCID mice by inoculation of mam-
mosphere cells with or without CAFs and NFs. The
results revealed that inoculation of 1 × 105 mammosphere
cells alone resulted in tumor formation in 60% of mice (3/
5), and coinoculation of 1 × 105 mammosphere cells with
1 × 105 CAFs significantly improved tumor formation (5/
5). Interestingly, coinoculation of 1 × 105 mammosphere
cells with 1 × 105 NFs sharply decreased tumorigenicity,
only 20% mice developed tumors (1/5, Table 2). These
data strongly suggested that cancer stromal fibroblast sig-
nificantly promote the tumorigenicity of mammosphere
cells.
The cocultured medium of primary mammosphere cells 
with CAFs had higher SDF-1 expression
The marked effects of cancer stromal niche promote us to
investigate the molecular mechanisms by which CAFs
increased the tumorigenicity of mammosphere cells.
Recent reports have indicated that SDF-1 boosts the pro-
liferation of several cancer cell lines in culture, including
breast carcinoma cells [10]. In order to determine
whether SDF-1 involved in the proliferation of
CD44+CD24- cells, the production of SDF-1 in mammo-
sphere cultures subject to various treatments were mea-
sured by ELISA. The result indicated elevated levels of
SDF-1 protein in the medium conditioned by the CAFs as
compared with that by mammosphere cells alone (426.4 ±
30.6 pg/ml vs. 283.6 ± 35.1 pg/ml, P < 0.05). In addition,
the cocultured medium of mammosphere cells with NFs
significantly decreased the production of SDF-1 (52.9. ±
13.1 pg/ml vs. 283.6 ± 35.1 pg/ml, P <0.01) (Fig. 4). These
Figure 2 Immunohistochemistry of NFs and CAFs. (A) Phase imag-
es of primary cultures of stromal fibroblasts isolated from invasive duc-
tal carcinomas (right) and stromal fibroblasts from normal breast tissue 
(left), original magnification × 100. (B) CAFs (right) were positive for α-
SMA staining, while NFs (left) were negative.
Table 1: Different MFE and cell number when cocultured with different stromal fibroblasts
Culture Condition MFE (%) Cell Number (× 105)
Monoculture 8.1 ± 0.7 1.51 ± 0.43
Mammosphere + CAFs 13.5 ± 1.2** 3.82 ± 0.41**
Mammosphere + NFs 5.2 ± 0.6* 0.65 ± 0.22*
*P < 0.05, **P < 0.01 compared with monocultureHuang et al. Journal of Experimental & Clinical Cancer Research 2010, 29:80
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results exhibited the similar trend as MFE, generation of
CD44+CD24- cells and tumorigenicity of mammosphere
cells by CAFs, implying that the elevated production of
SDF-1 by CAFs may be the reason for the promoted MFE,
generation of CD44+CD24- cells and tumorigenicity of
mammosphere cells.
CXCR4 antagonist reduced the generation of CD44+CD24- 
cells
In order to further prove whether enhanced generation of
CD44+CD24- cells by CAFs is mediated by SDF-1 and its
receptor CXCR4, we detected CXCR4 expression in
mammosphere cells and monolayer cells by qRT-PCR.
The results showed that CXCR4 mRNA expression was
higher in mammosphere cells than that in monolayer
cells, (P < 0.01, Fig. 5), and CXCR4 antagonist AMD3100
could decrease CXCR4 gene expression in both cells.
Moreover, AMD3100 significantly reduced MFE and
mammosphere cell number in monoculture mammo-
spheres and cocultured mammospheres with CAFs and
NFs (Table 3), and decreased the proportion of
CD44+CD24-  cells (Fig. 6, and see Additional file 2).
Figure 3 Mammosphere cells were cocultured with different stromal fibroblasts and flow cytometry was used to measure CD44 and CD24 
expression. (A) Mammosphere cells (1 × 105 cells/dish) cocultured with different stromal fibroblasts (1 × 105 cells/dish) using transwells for six days, 
and mammosphere cells cocultured with CAFs (middle) had the highest MFE (13.5 ± 1.2%), compared with monoculture mammosphere cells (left) 
(8.1 ± 0.7%), P < 0.01. (B) Flow cytometry analysis to measure CD44 and CD24 expression of cells derived from monoculture mammosphere cells and 
cocultured mammosphere cells. The expression of CD44+CD24- in monoculture mammosphere cells (left) was (17.2 ± 2.3%). Compared to monocul-
ture mammosphere cells, the expression of CD44+CD24- in cocultured mammosphere cells with CAFs (middle) was (21.4 ± 1.8%), P < 0.05, and the 
expression of CD44+CD24- in cocultured mammosphere cells with NFs (right) was (8.7 ± 0.9%), P < 0.01. The data were provided as the mean ± SD. 
Each experiment was performed three times.
Table 2: Incidence of tumors by coinoculation of mammosphere cells with CAFs and NFs in NOD/SCID mice
Cells Inoculated Mammosphere Mammosphere + CAFs Mammosphere + NFs
Tumors 3/5 5/5* 1/5*
*P < 0.01 compared with the same inoculation number of mammosphere cells alone.Huang et al. Journal of Experimental & Clinical Cancer Research 2010, 29:80
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These results collectively demonstrated that CAFs
enhanced generation of CD44+CD24- cells in mammo-
spheres may be caused by SDF-1/CXCR4 signaling.
Discussion
Mammosphere culture system is now widely used for
stem cell culture. Dontu and his colleagues had developed
an in vitro cultivation system that allowed for the prolif-
eration of undifferentiated human mammary epithelial
cells in suspension. When cultured on nonadherent sur-
faces in the presence of growth factors, nonadherent
mammospheres were enriched in cells with functional
characteristics of stem/progenitor cells [18]. Another
study also showed that breast tumorigenic cells with self-
renewal could be propagated in vitro as nonadherent
mammospheres [7]. Consistent with the above reports,
our study shows that mammosphere cells could be cul-
tured in suspension and generate BCSCs with the
CD44+CD24-  phenotype. Thus, long-term cultures of
mammosphere in vitro may represent a suitable model to
study BCSCs.
Stem cell properties in normal and malignant tissues
are tightly regulated by the Wnt, Shh and Notch signaling
pathways [19-21]. Notch signaling has been implicated in
the regulation of cell-fate decisions such as self-renewal
of adult stem cells and differentiation of progenitor cells
along a particular lineage. Dontu and his colleagues dem-
onstrated that Notch activation promoted mammary
stem cell self-renewal, but modulation of this pathway
had no significant effect on differentiated mammary epi-
t h e l i a l  c e l l s  [ 2 0 ] .  I n  b r e a s t  c a n c e r s ,  i t  w a s  f o u n d  t h a t
BCSCs preferentially expressed some "stemness" genes,
including Notch1 and β-catenin [18]. Our qRT-PCR anal-
ysis obtained the similar result that Notch2 and β-catenin
w e r e  e x p r e s s e d  a t  h i g h e r  l ev e l s  i n  m a m m o s p h e r e  c e l l s
than in monolayer cells, suggesting that Notch2 and β-
catenin are involved in BCSC regulation.
Recent studies have indicated that tumor niches play an
important role in regulating the growth and metastasis of
primary tumors. For example, in cocultured experiments,
CAFs extracted from human breast carcinomas were
more competent in promoting the growth of admixed
breast carcinoma cells than NFs that derived from the
same patients [22]. Similarly, when exposed to the condi-
tioned medium of pancreatic stellate cells isolated from
resected pancreatic adenocarcinoma, pancreatic epithe-
lial cells showed an increase in proliferation, migration,
invasion and colony formation in soft agar in a dose-
dependent manner [2,3].
It is well known that expression of α-SMA is a defining
characteristic of myofibroblasts [24], which activates the
growth of fibroblasts in areas of inflammation during
wound healing [25]. Our results demonstrated that
human mammary carcinomas, from which we had
extracted CAFs, carried large numbers of myofibroblasts
in their stroma. In this study, we found that CAFs up-reg-
ulated the proportion of CD44+CD24- cells in mammo-
spheres, whereas NFs down-regulated it in
mammospheres, implying that the CAFs have positive
effects on CD44+CD24- cell generation, while NFs have
negative effects on it. Furthermore, coinoculation of
Figure 4 The SDF-1 protein expression in cocultured medium of 
mammosphere cells with CAFs and NFs. The SDF-1 protein level in 
the medium conditioned by the CAFs was (426.4 ± 30.6) (pg/ml) (mid-
dle), compared to the levels produced by mammosphere cells alone 
(283.6 ± 35.1) (pg/ml) (left), P <0.05. The cocultured medium of mam-
mosphere cells with NFs (right) showed a far lower level of SDF-1(52.9. 
± 13.1) (pg/ml) secretion when compared with mammosphere cells 
alone, P <0.01. The SDF-1 level was measured three times in each ex-
periment.
Figure 5 Mammosphere cells and monolayer cells were cultured 
in the presence of 1 μg/ml AMD3100 for 48 h. qRT-PCR showed that 
CXCR4 mRNA expression in mammosphere cells was 3.9 fold higher 
than that in monolayer cells, (P <0.01), and AMD3100 could significant-
ly down-regulate it in both when treated for 48 h.
Table 3: AMD3100 significantly inhibited MFE and cell 
number when cocultured with different stromal fibroblasts
Culture Condition MFE (%) Cell Number
(× 105)
Monoculture 1.6 ± 0.1 0.22 ± 0.07
Mammosphere + CAFs 2.3 ± 0.2 0.43 ± 0.14
Mammosphere + NFs 1.5 ± 0.2 0.28 ± 0.08
*P < 0.01 compared with no treatment of AMD3100.Huang et al. Journal of Experimental & Clinical Cancer Research 2010, 29:80
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mammosphere cells with CAFs into NOD/SCID mice
significantly increased tumorigenicity as compared to
those obtained with mammosphere cells alone or with
NFs. This might be attributed to the enhanced generation
of mammosphere CD44+CD24- cells by CAFs.
Importantly, endogenous CXCR4 expression on carci-
noma cells is known to correlate with a poor prognosis
for several types of carcinomas [26,27]. The knockdown
of CXCR4 expression by a small interfering RNA in
breast carcinoma cells decreases cell invasion and prolif-
eration in vitro and abrogates the tumor growth in vivo
[28,29]. Furthermore, the selective blocking of the
CXCR4 by plerixafor overcome the protective effect of
the bone marrow environment for BCR-ABL(+) leukemia
[30]. Consistent with the above findings, our results sug-
gested that CXCR4 gene is expressed in mammosphere
cells at higher levels than that in monolayer cells. So we
hypothesized that CAFs enhanced the proliferation of
CD44+CD24-  cells in secondary mammosphere cells
through CXCR4.
Essential SDF-1/CXCR4 interactions have been
increasingly demonstrated in various tissues and culture
systems and it is possible that SDF-1/CXCR4 initiated
different signal pathways for cell proliferation and migra-
tion [27,31,32]. In malignant tumors, SDF-1/CXCR4 may
provide paracrine signals in promoting malignant pro-
gression such as metastasis, invasion and cell prolifera-
tion [33-35]. We found in this study that SDF-1 was
highly released in the conditioned medium of mammo-
sphere cells with CAFs, compared with NFs. In addition,
the interaction of SDF-1 released from CAFs and CRCX4
expressed on mammosphere cells is at least partly
involved in the proliferation of mammosphere. Thus, it is
likely that SDF-1 secreted by stromal myofibroblasts sig-
nificantly affects CXCR4-expressing mammosphere cells
through direct paracrine stimulation. This was further
proved by CXCR4 antagonist AMD3100, which signifi-
cantly reduced MFE and the expression of BCSC markers
in secondary mammosphere cells.
Figure 6 Mammosphere cells were cocultured with different stromal fibroblasts with the administration of AMD3100 and flow cytometry 
was used to measure CD44 and CD24 expression. (A) Mammosphere cells were cocultured with different stromal fibroblasts with the administra-
tion of AMD3100 (1 μg/ml) for six days. As a result, MFE in monoculture mammosphere cells (left), cocultured mammosphere cells with CAFs (middle) 
and NFs (right) was significantly reduced to (1.6 ± 0.1%), (2.3 ± 0.2%) and (1.5 ± 0.2%), respectively. (B) Flow cytometry analysis was used to measure 
CD44 and CD24 expression of cells derived from mammosphere cells. The expression of CD44+CD24- in monoculture mammosphere cells (left), cocul-
tured mammosphere cells with stromal CAFs (middle) and NFs (right) was (2.2 ± 0.3%), (4.4 ± 0.8%) and (2.7 ± 0.3%), respectively. The data were pro-
vided as the mean ± SD. Each experiment was performed three times.Huang et al. Journal of Experimental & Clinical Cancer Research 2010, 29:80
http://www.jeccr.com/content/29/1/80
Page 9 of 10
Collectively, these data indicated that the specific inter-
actions of SDF-1 with their receptor CXCR4 that
expressed on mammosphere cells are likely to occur in
tumor-stromal niches, and these interactions may be
responsible for the proliferation of CD44+CD24- cells.
The proliferation of mammosphere cells was observed to
be promoted by being cocultured with CAFs, suggesting
that SDF-1/CXCR4 signaling is involved in the cell prolif-
eration of these cocultured mammosphere cells. CXCR4
and SDF-1 are candidate factors that involved in the
cross-talk of the tumor-niche interaction of CD44+CD24-
cells. Because the increase in the proliferation of cocul-
tured mammosphere cells induced by SDF-1 was com-
pletely inhibited by AMD3100, therapeutic strategies that
target SDF-1/CXCR4 may be beneficial to breast cancer
patients. So, new strategies need to take into account the
role of the niches that can have a critical role in modulat-
ing BCSCs and response to therapeutic agents. It should
be noted that this study had only examined the interac-
tion of stromal fibroblasts and CD44+CD24- cells in two
dimensions, and how they interact with each other in
three-dimensional culture remains to be further studied.
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